Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Congratulations on 1000 posts. You must be a campanologist with a name like that.
Oh dear, sour grapes or what. Why don't you take a look, you might just get your money back. They are virtually the same price.
Yes, Justin Waite was praising ANIC the othe day, so I will take a look tomorrow. I'm in IQ-AI which is in the same situation. I pulled out of SXX a while ago because the loan and payback figures looked frightening, plus a 23mile conveyor? Very problematic. GL to all holders.
You must always view share dealing from the point of view of the MMs, whose job is to rob you blind, and they are very good at it. This morning's RNS did very little to encourage mass share buying, but the MMs put the price up anyway just to catch those who decided to buy on the news. once the buying dies down so does the SP. The usual trick is to now drop the price into the red to encourage selling, which the nervous often do. The price will only rise rapidly if there is buying pressure or the MMs want you to think that something is about to happen, which normally doesn't and the SP returns to below where it was before with lots of disillusioned punters selling at a loss. Then there's the dreaded treeshake, which is why I don't use stop losses. I think that SKIN has tremendous potential, but like VRS, AVCT, RENE and IQAI they are all just on the cusp of becoming huge, it just takes time and patience. GL.
I thought that that would be the case as the RNS stated that no new information would be disclosed at this time. Thanks for your thoughts. I would like to see Investors Chronicle proved wrong as well.
Lovely job. Here's hoping.
I have never been invested in a company that was waiting for FDA approval and subsequently received it. Hopefully this will be the first.
Is there any feedback from the demo in Bristol or is everyone sworn to secrecy?
I see that "AJ" of IC has pronounced VRS a "sell" once again. With the information available I would have thought that the bare minimum of a "hold" would be more realistic. Maybe AJ is right, after all, he is a professional, but as a mere amateur, I think that he is wrong.
Found this on ADVFN Breakout. Very interesting, so I bought some.
I see that IC remains a "sceptical seller" with a sell recommendation by, I assume, Alex Janiaud (AJ). The "Beano" must have mentioned VRS at some point then.
Managed to buy in just in time then.
Although my largest holding is VRS, I am into RENE and AVCT and also AGL. However, I have found in recent months that the only way to make decent money is to take profit wherever possible and make the most of the volatility of these news driven shares.
I quite like the look of this company.
Can't buy any at the moment.
Many thanks researcher1. It would appear that there are some pretty impressive companies around at present that are on the verge of making some serious money over the next 2-3 years. Avacta is another one and probably Versarien, but the wait is a real tease. I will probably dip the toe in Angle shortly as I am finding the "eggs in one basket" situation too limiting. GL.
Thanks Seeingtom. I think that AGL could well be on the brink, but I will have to look further into revenues.GL.
I have been following AGL since it was 3p but have never understood where the revenue stream will come from. Is it sales of the parsortix equipment or as a service, would someone mind explaining please.
Just bought a few of these. Interesting looking company.
Nothing new there really except for the part about working with two of the worlds biggest biotech companies. I keep a reasonable holding of AVCT and expect to trade it on news, but I'll reinvest big time towards the end of 2020 when human trials begin. Still a very exciting company.